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Structured abstract 67 
Preventive cardiology encompasses the whole spectrum of cardiovascular disease (CVD) prevention, 68 
at individual and population level, through all stages of life. 69 
This includes promotion of CV health, management of individuals at risk of developing CVD,  and 70 
management of patients with established CVD, through interdisciplinary care in different settings.  71 
Preventive cardiology addresses all aspects of CV health in the context of the social determinants of 72 
health, including physical activity, exercise, sports, nutrition, weight management, smoking 73 
cessation, psychosocial factors and behavioural change, environmental, genetic and biological risk 74 
factors, and CV protective medications. 75 
 76 
This is the first European Core Curriculum for Preventive Cardiology, which will help to standardize, 77 
structure, deliver, and evaluate training in preventive cardiology across Europe. It will be the basis for 78 
dedicated fellowship programmes and a European Society of Preventive Cardiology (EAPC) 79 
subspecialty certification for cardiologists, with the intention to improve quality and outcome in CVD 80 
prevention. 81 
 82 
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Definition of preventive cardiology 143 
Preventive cardiology encompasses the whole spectrum of cardiovascular disease (CVD) prevention, 144 
at individual and population level, through all stages of life. 145 
This includes promotion of CV health, management of individuals at risk of developing CVD,  and 146 
management of patients with established CVD, through interdisciplinary care in different settings.  147 
Preventive cardiology addresses all aspects of CV health in the context of the social determinants of 148 
health, including physical activity, exercise, sports, nutrition, weight management, smoking 149 
cessation, psychosocial factors and behavioural change, environmental, genetic and biological risk 150 
factors, and CV protective medications. 151 
Preventive cardiology – towards a sub-specialty of cardiology 152 
Scientific advances have led to a substantial decline of death from CVD over the last decades.1 153 
However, CVD morbidity remains high and CVD are still the most common cause of death across 154 
European Society of Cardiology (ESC) member countries.2 While positive trends have been observed 155 
for medical management of arterial hypertension and dyslipidaemias, the prevalence of obesity has 156 
more than doubled and the prevalence of diabetes mellitus has tripled in Europe.2 More recent 157 
declines in the age-standardized incidence of CVD across ESC member countries have been small or 158 
absent.2 The incidence of CVD’s major components, ischaemic heart disease, and stroke, have both 159 
shown a downward trend but changes in prevalence have been small.2 In a European Heart Network 160 
study, CVD was estimated to cost the European Union economy 210 billion Euro a year in 2015, of 161 
which 53% (111 billion Euro) was due to healthcare costs.2 162 
The cardiology community has started a transition from predominantly treatment to prevention of 163 
CVD.3 A large body of scientific evidence has been generated and appropriate guidelines and position 164 
papers are available in the four domains of preventive cardiology: Population science and public 165 
health,4, 5 primary prevention and risk factor management,3, 6-8 secondary prevention and 166 
cardiovascular rehabilitation,3, 9-14 and sports cardiology and exercise.15-21 The European Association 167 
for Preventive Cardiology (EAPC) has recently started centre accreditation in these domains to 168 
standardise and optimise care.22  169 
Historically, CV prevention has been classified into primordial prevention (population-based 170 
measures to prevent risk factor development), primary prevention (management of individuals 171 
without clinically manifest disease but at risk of developing CVD, with the aim of delaying or 172 
preventing the onset of disease), and secondary prevention (focusing on people with established 173 
CVD). While preventive measures indeed differ in various ways for these three categories, this Task 174 
Force also acknowledges that CV risk is a continuum and that several measures to enhance CV health 175 
are applicable across the spectrum of CV prevention. Moreover, the distinction between primary and 176 
secondary prevention, albeit well-established, may in certain occasions be artificial; while people 177 
with subclinical disease (e.g. evidence of advanced atherosclerosis by imaging, but not yet with 178 
clinically manifest CVD) would formally belong to “primary prevention”, they often qualify for 179 
interventions applicable to the “secondary prevention” setting.    180 
Both in high, middle, and low income countries, nine potentially modifiable health behaviours and CV 181 
risk factors account for most of the population attributable risk of myocardial infarction and stroke in 182 
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both sexes and at all ages.23, 24 Smoking, physical inactivity, unhealthy nutrition patterns, obesity, 183 
psychosocial factors, diabetes mellitus, dyslipidaemias, and arterial hypertension are key targets for 184 
lifestyle interventions, and optimisation of medical therapy. In addition, biomarkers and genetics risk 185 
scores25 have the potential to further characterize individual CVD risk profiles. Beyond traditional risk 186 
factors, other drivers of residual CV risk have come to the forefront, including inflammatory, pro-187 
thrombotic, and metabolic pathways that contribute to recurrent events and are often unrecognized 188 
and not addressed in clinical practice.26   189 
The increasing rates of obesity and diabetes, the suboptimal lifestyle management and 190 
implementation of guideline-directed medical therapy in secondary prevention of CVD,27 and the 191 
gaps in evidence highlight the need for further investment in preventive cardiology. The level of 192 
profound knowledge, specialised skills, and committed attitudes goes beyond general cardiology 193 
training and justifies sub-specialty training. In addition to expertise in a single CVD risk factor (e.g. 194 
diagnosis and management of dyslipidaemias), competencies are required to evaluate and manage 195 
single risk factors in the individual’s overall risk profile, take environmental, genetic, lifestyle and 196 
psychosocial aspects into account, integrate guideline-directed medical therapy, and propose a 197 
holistic management plan including attainable and realistic short-, mid,  and long-term goals. 198 
Motivational interviewing skills are required to gain the patient’s willingness to adhere to lifestyle 199 
changes and guideline-directed medical therapies in order to reach these goals. Leadership and 200 
communication skills are required to cooperate with interdisciplinary healthcare teams and other 201 
partners. Beside classical patient groups (individuals with CV risk factors, patients after acute 202 
coronary syndromes, or with chronic coronary syndromes, heart failure, implantable devices, 203 
peripheral artery disease), preventive cardiology can contribute to CV risk factor management in 204 
different patient populations, e.g. diabetes,6 atrial fibrillation,28 and cancer.29, 30 Moreover, specific 205 
aspects of sports cardiology will have to be covered (Figure 1). 206 
As a sub-specialty, a broader perspective of CVD prevention is necessary. Pregnancy, infancy, 207 
adolescence, early adulthood, adult and elderly life are distinct periods with individual potential 208 
opportunities for prevention. Pre-conception and pregnancy are important phases for the next 209 
generation, while post-mortem autopsy may reveal relevant information for living relatives (Figure 210 
2).31 Precision medicine and digital health start to play a role in CVD prevention and have the 211 
potential to improve phenotyping of patients for more personalised and tailored therapies, and 212 
better outcomes.32, 33 Emerging concepts inform new collaborations in the future and an expansion of 213 
the field of preventive cardiology.  214 
A common European core curriculum for preventive cardiology will help to standardize, structure, 215 
deliver, and evaluate training of cardiologists in preventive cardiology across Europe. This will be the 216 
basis for dedicated fellowship programmes and an EAPC sub-specialty certification, contributing to 217 
improvements of quality and outcome in CVD prevention. Similar initiatives have been launched in 218 
the United States of America.34-36 In the evolving field of preventive cardiology, the core curriculum 219 
will have to be updated at regular intervals to include emerging concepts and new scientific 220 
evidence.   221 
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The concept of the core curriculum for preventive cardiology 222 
The changing nature of our profession and the changing environment of healthcare has led to 223 
specific requirements in the field of cardiology. In 2007, the European Board for the Specialty of 224 
Cardiology (EBSC) published recommendations for sub-specialty accreditation in cardiology.37 A sub-225 
specialty is defined as a specific field of cardiology, where knowledge and skills go beyond the basic 226 
requirements of general cardiology and additional training is necessary. Sub-specialty training should 227 
be based on a published core curriculum.37 The core curriculum should include a formal education 228 
plan intended to bring expected learning outcomes. It should include the rationale, aims, and 229 
objectives, expected learning outcomes, education content, teaching and learning strategies, and 230 
assessment procedures. The syllabus should be part of the curriculum and is a listing of subject 231 
matters to be covered in a training programme.37 232 
Over the last decades, sub-specialty curricula have been developed and published by most ESC 233 
associations (Acute Cardiovascular Care, Arrhythmias & Cardiac Pacing, Heart Failure, Cardiovascular 234 
Imaging, Percutaneous Cardiovascular Interventions).38  In the field of preventive cardiology, the 235 
American College of Cardiology (ACC)/American Heart Association (AHA) published a competence 236 
and training statement in 2009.34 More recent proposals for sports cardiology qualification are 237 
available from the ACC and EAPC.16, 39  238 
This document is the first common European core curriculum for preventive cardiology, covering all 239 
aspects of the field, including prevention, rehabilitation, and sports cardiology. It should serve as a 240 
framework for the sub-specialty qualification of cardiologists in preventive cardiology. The 241 
description of practical educational programmes, requirements for training centres and trainers is 242 
out of the scope of this document, and will be addressed in future documents. Advanced 243 
competencies in sports cardiology may be required in dedicated referral centres, addressed by a 244 
specific additional curriculum.  245 
A core curriculum task force was established in 2019, including members of the EAPC Education 246 
Committee, the EAPC Board, and the EAPC Young Community. A writing group, including 247 
representatives of the four EAPC sections contributed to the drafting of the entrustable professional 248 
activities (EPAs).40 Their views and comments were captured in an iterative process employing 249 
teleconferences, in-person discussions, an online Delphi survey, and workshops at EAPC meetings.  250 
The document was developed in cooperation with the task force of the ESC Core Curriculum for the 251 
Cardiologist.41 Key competencies from the field of preventive cardiology are important for the 252 
general cardiologist and covered in Chapter 8 on prevention, rehabilitation, and sports.41 This chapter 253 
was used during the drafting process of this document, and served as a guideline to harmonise 254 
structure and content. The intention of this core curriculum is to describe the additional knowledge, 255 
skills, and attitudes necessary for sub-specialty qualification in preventive cardiology. The final 256 
document was approved by the EAPC Board in October 2020, and reviewed by the ESC Education 257 
Committee.  258 
   259 
1. CanMEDS roles 260 
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The Royal College of Physicians and Surgeons of Canada have produced a widely accepted 261 
standard framework of physician roles, CanMEDS.42 This framework was built to identify and 262 
describe the abilities physicians require to effectively meet the health care needs of the people 263 
they serve (Table 1).42 The ESC has adopted the CanMEDS roles in the ESC Core Curriculum for 264 
the Cardiologist.41  265 
CanMEDS roles can be assessed and taught individually, and they are all represented to a 266 
different extend in each of the EPAs of the Core Curriculum for Preventive Cardiology as outlined 267 
in chapters 1 to 5. While EPAs are proposed as the preferred method of assessing specialty 268 
competencies, the CanMEDS roles can be viewed as generic competencies of physicians.  269 
In the field of preventive cardiology, physicians work in interdisciplinary teams and the scope of 270 
cardiovascular prevention goes beyond patient care. Thus, the CanMEDs roles of communicator, 271 
collaborator, and health advocate are of particular importance. 272 
 273 
2. Clinical competencies 274 
The conceptualization, organization, and administration of preventive cardiology involves 275 
different groups of health care professionals. In the context of this curriculum, we focus on the 276 
competences of the cardiologist to administer of preventive cardiology in clinical practice. 277 
In addition to the clinical competencies acquired during general cardiology training,41 the sub-278 
specialty of preventive cardiology requires specific knowledge, skills and appropriate attitudes in 279 
primary prevention, risk factor assessment and management, population science, public health, 280 
secondary prevention, rehabilitation, sports cardiology, and exercise testing and training. 281 
The number of clinical competencies calls for assessment throughout sub-specialty training. 282 
Within the process of continuous professional development, this may encourage continuous 283 
learning which will continue after sub-specialist certification. To enable these goals, the core 284 
curriculum consists of EPAs (see below). To make knowledge accessible, each EPA contains a 285 
detailed map linking to contemporary guidelines and position papers and the ESC topic list, 286 
thereby enabling cross-linking with knowledge and training databases including textbooks, 287 
structured and case-based learning courses, congress programmes, and online materials.41 288 
 289 
3. Entrustable professional activities 290 
Trust is not only central for the relationship between trainers and trainees, but also in the 291 
shared-decision-making process between physicians and their patients, and in the interaction 292 
with other health care professionals.41 An EPA is a key task of a discipline that an individual can 293 
be trusted to perform in a given health care context, once sufficient competence has been 294 
demonstrated.40 The EPA concept allows trainers to make competency-based decisions about the 295 
level of supervision required by trainees.40 Competency-based education targets standardized 296 
levels of proficiency to guarantee that all learners have a sufficient level of proficiency at the 297 
completion of training.40 EPAs are not an alternative for competencies, but a means to translate 298 
competencies into clinical practice. While competencies are descriptors of physicians, EPAs are 299 
descriptors of work. EPAs usually require multiple competencies in an integrative holistic 300 
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nature.40 EPAs are observable and measurable and can be mapped to competencies and 301 
milestones across the entire landscape of physician activities. They can be monitored, 302 
documented, and certified.41 303 
The American Board of Pediatrics was one of the first certifying agencies that introduced the 304 
concept of EPAs in their revised training guideline for the sub-specialty of paediatric cardiology in 305 
2015.43 The ESC has introduced EPAs in the 2020 update of the ESC Core Curriculum for the 306 
Cardiologist, containing one chapter on prevention, rehabilitation, and sports with seven EPAs.41 307 
The nine EPAs of the EAPC Core Curriculum for Preventive Cardiology describe the additional 308 
competencies necessary for the sub-specialty of preventive cardiology and are grouped in 309 
chapters, according to specific domains of preventive cardiology (Table 2).  310 
All EAPC sections were involved in the definition of the content.  The EPA 2.2, Manage a patient 311 
with non-traditional cardiovascular risk factors, builds upon the competencies required for EPA 312 
2.1, Manage individuals with multifactorial cardiovascular risk profiles, and the knowledge, skills, 313 
and attitude sections emphasise additional and particularly relevant aspects only. The same 314 
applies to EPA3.2, Manage a prevention and rehabilitation programme for a cardiovascular 315 
patient with significant comorbidities, frailty, and/or cardiac devices, and EPA 3.1, Manage a 316 
prevention and rehabilitation programme for a cardiovascular patient. The EPA 5.1, Use 317 
cardiopulmonary exercise testing for diagnosis, risk stratification and exercise prescription, deals 318 
with a testing modality, specific for preventive cardiology, since independent execution and 319 
interpretation is not required for the general cardiologist.41 This EPA is relevant in all domains of 320 
preventive cardiology. 321 
All EPAs of this core curriculum share a common structure. The clinical competence is defined in 322 
the title, followed by a description of scope and timeframe, setting, including and excluding 323 
situations and procedures. Relevant roles of the CanMEDS Physician Competency Framework are 324 
mentioned.42 Knowledge, skills, and attitudes are formulated as learning outcomes, and 325 
assessment tools are recommended. The required level of independence is mentioned. Related 326 
ESC Guidelines and EAPC Position Papers are included as primary sources of knowledge. Relevant 327 
topics from the ESC topic list for each EPA are summarized in a supplemental data file.  328 
 329 
 330 
4. Level of independence 331 
The level of entrustment or independence for executing an EPA will change during the training 332 
period (Table 3). At a certain time of the training, trainees may have different levels of 333 
independence in different EPAs.41 Given the broad spectrum of CVD prevention, sub-specialty 334 
training is not intended to achieve level of independence of 5 in all EPAs. For the following three 335 
EPAs, a lower level of independence is recommended.  336 
1.1 Design, implement and evaluate preventive interventions at the population level 337 
2.2 Manage a patient with non-traditional cardiovascular risk factors 338 
4.2 Manage the work-up of an athlete with suspected or known cardiovascular disease 339 
 340 
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 341 
5. Assessment of clinical competences using EPA’s 342 
One important aspect in the concept of EPAs is the assessment of clinical competencies. EPAs 343 
provide a framework for trainers to perform easy, formative and repeated assessments of 344 
trainees during their sub-specialty training, which help to adjust the trainee’s level of 345 
independence.41 Optimally, these assessments should be integrated into routine clinical care. The 346 
competencies of the trainees will further increase after completing the training in line with their 347 
continuous professional development. Consulting more experienced colleagues or other experts 348 
in complex cases should not be judged as need for supervision, but as a clinical reality in times of 349 
rapid increasing medical knowledge. When a trainee is able to execute an EPA in routine cases in 350 
an independent manner and to assume the expected professional responsibilities, the highest 351 
level of independence is achieved. 352 
Suitable tools for the assessment of EPAs depend on the nature of the activity and are proposed in 353 
the assessment section of each EPA (Table 3).41 354 
 355 
Sources of knowledge in preventive cardiology 356 
In addition to specific guidelines and position papers provided at the end of each EPA, the ESC has 357 
published four textbooks in the field of preventive cardiology as additional source of comprehensive 358 
knowledge.44 359 
• ESC Textbook of Preventive Cardiology 2015 360 
• ESC Handbook of Preventive Cardiology 2016 361 
• ESC Textbook of Sports Cardiology 2019 362 
• ESC Handbook of Cardiovascular Rehabilitation 2020 363 
  364 
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Table 1 CanMEDS Physician Competency Framework, modified and adopted from the Royal College 365 
of Physicians and Surgeons of Canada, with permission42 366 
 367 
Role Description Key Competencies 
Medical Expert As medical experts, physicians 
integrate all of the CanMEDS 
roles, applying medical 
knowledge, clinical skills, and 
professional values in their 
provision of high-quality and 
safe patient-centred care. 
Medical expert is the central 
physician role in the CanMEDS 
framework and defines the 
physician’s clinical scope of 
practice. 
• Practise medicine within their 
defined scope of practice and 
expertise 
 
• Perform a patient-centred clinical 
assessment and establish a 
management plan 
 
• Plan and perform procedures 
and therapies for the purpose of 
assessment and/or management 
 
• Establish plans for ongoing care 
and, when appropriate, timely 
consultation 
 
• Actively contribute, as an 
individual and as a member of a 
team providing care, to the 
continuous improvement of health 
care quality and patient safety 
 
• Apply novel digital methods of 
diagnosis, treatment 
communication and process to 
achieve optimal clinical outcomes 
Communicator As communicators, physicians 
form relationships with patients 
and their families that facilitate 
the gathering and sharing of 
essential information for 
effective health care. 
• Establish professional therapeutic 
relationships with patients and 
their families (in-person and virtual 
communication) 
 
• Elicit and synthesize accurate and 
relevant information, incorporating 
the perspectives of patients and 
their families 
 
• Share health care information 
and plans with patients and their 
families 
 
• Engage patients and their families 
in developing plans that reflect 
the patient’s health care needs and 
goals 
 
• Document and share written and 
electronic information about the 
medical encounter to optimize 
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clinical decision-making, patient 
safety, confidentiality, and privacy 
Collaborator As Collaborators, physicians 
work effectively with other 
health care professionals to 
provide safe, high-quality, 
patient-centred care. 
• Work effectively with physicians 
and other colleagues in the health 
care professions 
 
• Work with physicians and other 
colleagues in the health care 
professions to promote 
understanding, manage 
differences, and resolve conflicts 
 
• Hand over the care of a patient to 
another health care professional 
to facilitate continuity of safe 
patient care 
Leader As Leaders, physicians engage 
with others to contribute to a 
vision of a high-quality health 
care system and take 
responsibility for the delivery of 
excellent patient care through 
their activities as clinicians, 
administrators, scholars, 
or teachers 
• Contribute to the improvement 
of health care delivery in teams, 
organizations, and systems 
 
• Engage in the stewardship of 
health care resources 
 
• Demonstrate leadership in 
professional practice 
 
• Manage career planning, finances, 
and health human resources in a 
practice 
Health Advocate As Health Advocates, physicians 
contribute their expertise and 
influence as they work with 
communities or patient 
populations to improve health. 
They work with those they 
serve to determine and 
understand needs, speak on 
behalf of others when required, 
and support the mobilization of 
resources to effect change. 
• Respond to an individual patient’s 
health needs by advocating with 
the patient within and beyond the 
clinical environment 
 
• Respond to the needs of the 
communities or populations they 
serve by advocating with them for 
system-level change in a socially 
accountable manner 
Scholar As Scholars, physicians 
demonstrate a lifelong 
commitment to excellence in 
practice through continuous 
learning and 
by teaching others, evaluating 
evidence, and contributing to 
scholarship. 
• Engage in the continuous 
enhancement of their professional 
activities through ongoing 
learning 
 
• Teach students, residents, the 
public, and other health care 
professionals 
 
• Integrate best available evidence 
into practice 
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• Contribute to the creation and 
dissemination of knowledge and 
practices applicable to health 
Professional As Professionals, physicians are 
committed to the health and 
well-being of individual patients 
and society through 
ethical practice, high personal 
standards of behaviour, 
accountability to the profession 
and society, physician-led 
regulation, and maintenance of 
personal health 
• Demonstrate a commitment to 
patients by applying best practices 
and adhering to high ethical 
standards 
 
• Demonstrate a commitment 
to society by recognizing and 
responding to societal expectations 
in health care 
 
• Demonstrate a commitment to the 
profession by adhering to 
standards and participating in 
physician-led regulation 
 
• Demonstrate a commitment to 
physician health and well-being to 
foster optimal patient care 
 368 
 369 
Table 2 Comparison of Entrustable Professional Activities between the 2020 ESC Core Curriculum for 370 
the Cardiologist and the 2021 EAPC Core Curriculum for Preventive Cardiology. 371 
Preventive cardiology 
domains 
ESC Core Curriculum for the 
Cardiologist 
EAPC Core Curriculum for 
Preventive Cardiology 
Population science and public 
health 
 - Design, implement and 
evaluate preventive 
interventions at the population 
level 
Primary prevention and risk 
factor management 
- Manage a patient with 
hypertension 
 
- Manage a patient with 
dyslipidaemia 
 
- Manage cardiovascular 
aspects in a diabetic patient 
 
- Manage a cardiac patient in 
primary prevention 




- Manage a patient with non-
traditional cardiovascular risk 
factors  
 
Secondary prevention and 
cardiovascular rehabilitation 
- Manage a cardiac patient in 
secondary prevention 
 
- Prescribe a prevention and 
rehabilitation programme for a 
cardiovascular patient 
 
- Manage a prevention and 
rehabilitation programme for a 
cardiovascular patient 
 
- Manage a prevention and 
rehabilitation programme for a 
cardiovascular patient with 
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significant comorbidities, 
frailty,  and/or cardiac devices 
 
- Manage a cardiovascular 
prevention and rehabilitation 
programme for an oncology 
patient 
Sports cardiology and exercise - Manage cardiovascular 
aspects in an athlete 
- Manage pre-participation 
screening in a competitive 
athlete 
 
- Manage the work-up of an 
athlete with suspected or 
known cardiovascular disease 
All  - Use cardiopulmonary 
exercise testing for diagnosis, 




Table 3 Level of independence for a profession activity, adopted from41 374 
Level 1 Trainee is able to observe 
Level 2 Trainee is able to perform the activity under direct supervision 
(proactive, supervisor in the room) 
Level 3 Trainee is able to perform the activity under indirect supervision 
(reactive, on-demand supervision, supervisor readily available) 
Level 4 Trainee is able to perform the activity under distant supervision 
(reactive, supervision available remotely or post-hoc) 




Table 3 Tools for the assessment of clinical competencies, adopted from the ESC Core Curriculum for 377 
the Cardiologist41 378 
Knowledge • Self-assessment with multiple choice questions (MCQs), e.g. provided 
after a webinar 
Skills • Case-based discussions 
• Direct observation of procedural skills (DOPS) 
• Workplace-based Assessments 
• Mini clinical evaluation exercise (mini-CEX) 
Attitudes • Multiple consultant reports 
• Multi-source feedback 
  379 
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Chapter 1: Population science and public health 380 
1.1 Design, implement and evaluate preventive interventions at the 381 




Scope and timeframe:  
All public health interventions in the field of CVD prevention 







Identification of potential needs of a population and preventive interventions 
Review of past and ongoing community cohorts 
Selection of the appropriate lifestyle and pharmacological interventions 
Setting up budget, timeframe, milestones and main outcomes for the interventions 
Setting up the criteria for the evaluation of the interventions 
Setting up occupational health programs 
Setting up population screening programs (e.g. schools, workplaces) 
Implementing the interventions 
Collecting information regarding outcomes/milestones as well as cost-effectiveness 
Synthesizing the results and disseminating to stakeholders / collaborators / general population 
 
Excluding:  














• Identify target populations and preventive interventions, including groups currently 
underrepresented in clinical studies (women, older people, ethnic minorities, migrants) 
• Appraise the evidence regarding population-based approaches to prevention (e.g. 
epidemiology, randomised controlled trials, and cost effectiveness studies) 
• Be aware of potential stakeholders and collaborators 
• Design studies to check safety and success of interventions 
• Describe research methodology to collect data / run analysis / synthesize results of 
study outcomes / use audit tools 





• Build a network of collaborators to identify and engage with key stakeholders, including 
policy makers, health services, health care professionals, academia and members of the 
public 
• Conduct a needs assessment to identify the population priorities based on good 
knowledge of the local population 
• Integrate recommended interventions into existing preventive strategies on a 
population level  
• Design the interventions  
• Perform power calculations to determine sample sizes required to  evaluate the 
interventions with confidence 
• Create, validate and implement data collection tools (questionnaires, instruments to 
collect clinical data) 
• Evaluate statistical methods to analyse data taking into account possible biases/ 
confounders. 
• Calculate the cost-effectiveness of interventions   
• Use early public involvement and engagement  
• Engage communication channels to publicize the interventions 
• Disseminate results to professionals, the public and politicians  
• Evaluate effectiveness of implemented interventions, and recommend adjustments in 
preventive strategy if needed 




• Collaborate/negotiate with other stakeholders in planning of study 
• Communicate to ensure that the intervention is understood by the target population, 
the stakeholders and politicians 





• Case-based discussions, entrustment-based discussions 
• Multi-source feedback  
• Simulation of population interventions 
• Presentation and publication of results of the intervention 
 
Level of Independence 
 
• Level 3 (perform the activity under indirect supervision. In this context this means to 
contribute to design, implementation and evaluation of preventive interventions, and 
cooperate with partners from population science and public health, but not necessarily 
to take the lead in these type of projects) 
 
Related ESC Guidelines and EAPC Position Papers 
 
• Timmis A, Townsend N, Gale CP, et al. European Society of Cardiology: Cardiovascular Disease Statistics 
2019. Eur Heart J 2020; 41: 12-85.  
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• Arena R, Guazzi M, Lianov L, et al. Healthy lifestyle interventions to combat noncommunicable disease-a 
novel nonhierarchical connectivity model for key stakeholders: a policy statement from the American 
Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and 
Rehabilitation, and American College of Preventive Medicine. Eur Heart J 2015; 36:2097-2109. 
 
• Jorgensen T, Capewell S, Prescott E, et al. Population-level changes to promote cardiovascular health. Eur J 




Chapter 2:  Primary prevention and risk factor management 386 




Scope and timeframe:  
For every individual with known or suspected CV risk  
From first evaluation to follow-up, as advised by the clinical condition 
 
Setting:  
Primary care setting (including nursing home care), in-patient setting, out-patient setting, 
emergency department, community setting, workplace   
 
Including:  
Baseline assessment, identification of single or multiple risk factors and multi-morbidity 
Identification of individualised targets for CVD prevention using basic and advanced tools for 
investigation 
Use of risk modifiers, and imaging in intermediate risk individuals 
Guidance, lifestyle recommendations, guideline-directed medical therapy, referral, follow-up 
 
Excluding:  














• Discuss the epidemiology of CVD and its associated lifestyle, medical and psychosocial 
risk factors 
• Understand specific aspects of groups currently underrepresented in clinical studies 
(women, older people, ethnic minorities, migrants)  
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• Demonstrate an understanding of strategies for the reduction of CV risk across the life 
course  
• Understand the concept of risk and the role of risk estimation tools in CVD prevention 
• Understand the concept of precision medicine and deep phenotyping based on 
panomics and their current relevance for clinical decision making   
• Identify what individual/patient groups are at high risk for CVD and how they should be 
targeted for preventive care    
• Describe the key critical success factors for delivering effective CVD prevention 
programmes   
• Demonstrate an understanding of how the social determinants of health influence 
cardiovascular health and health inequalities 
• List the investigations used to diagnose multifactorial risk profiles 
• Demonstrate an understanding of lifestyle risk factor management, which includes 
smoking cessation, diet, and physical activity  
• Appraise the latest evidence-based guidelines for managing individuals with 




• Obtain a personal and family history 
• Explore patient expectations, values and priorities 
• Perform a thorough physical examination 
• Perform a comprehensive CV risk assessment using appropriate risk calculators and 
including additional tests, if necessary (blood tests, resting and exercise 
electrocardiography (ECG), cardiopulmonary exercise testing (CPET), cardiovascular 
imaging) 
• Assess cardiovascular and extracardiac comorbidities 
• Interpret the results of examination and tests showing abnormal values 
• Determine and compare the benefits of lifestyle interventions, pharmacology of drugs, 
or both for primary prevention 
• Manage CV risk factors in line with level of individual risk and evidence based guidelines 
and patient preference 
• Assess nutritional habits and integrate into nutritional strategy 
• Provide personalised lifestyle advice for smoking cessation, physical activity and 
exercise, nutrition and diet, stress management and psychological health 
• Participate as an interdisciplinary team member, working collaboratively with general 
practitioners, nurses, dietitians, physiotherapists, sports scientists, psychologists, 
occupational therapists, pharmacists and other professionals involved in CVD 
prevention 
• Apply effective communication and motivational skills to support the patient in making 
positive lifestyle and behaviour modifications    





• Adopt a non-judgmental attitude regarding individual lifestyle 
• Adopt a shared decision approach by actively engaging the patient in management 
decisions based on individual values, preferences, and associated conditions and co-
morbidities 
• Adopt a culture of interdisciplinary teamwork 
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• Recognise the importance of primary prevention in individuals and patients with 





• Direct observation, workplace-based assessments ( e.g. DOPS, mini-CEX, fieldnotes) 
• Case-based discussions, entrustment-based discussions 
• Multiple consultant reports  
• Multi-source feedback  
 
Level of Independence 
 
• Level 5 (perform the activity without supervision, teach and supervise others) 
 
Related ESC Guidelines and EAPC Position Papers 
 
• Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic 
coronary syndromes. Eur Heart J 2020; 41: 407-477. 
 
• Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: 
lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41: 111-188.  
 
• Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and 
cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020; 41: 255-323.  
 
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial 
hypertension. Eur Heart J 2018; 39: 3021-3104. 
 
• Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in 
clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on 
Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and 
by invited experts)Developed with the special contribution of the European Association for 








Scope and timeframe:  
For every individual with non-traditional CV risk factors, suitable for CVD prevention 
From first presentation to follow-up, as advised by clinical condition 
 
Setting:  
Primary care setting (including nursing home care), in-patient setting, out-patient setting, 
emergency department, community settings, workplace  
 
Including:  
Assessment of CV risk in patients with abnormal biomarkers, cancer therapy, chronic kidney 
disease, chronic obstructive pulmonary disease, inflammatory disease, congenital heart 
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disease, migraine with aura, erectile dysfunction, preeclampsia, gestational diabetes, sleep 
disorders 
Identification of residual CV risk and targets for CVD prevention using basic and advanced tools 
for investigation 
Guidance, lifestyle recommendations, guideline-directed medical therapy, referral, follow-up 
 
Excluding:  














• List important non-traditional CV risk factors and diseases with elevated CV risk (e.g. 
abnormal biomarkers, cancer therapy, chronic kidney disease, chronic obstructive 
pulmonary disease, congenital heart disease, inflammatory disease, migraine with 
aura, erectile dysfunction, preeclampsia, gestational diabetes, sleep disorders) 
• Describe the biopsychosocial spectrum of non-traditional CV risk factors and recognize 
their importance for CVD primary prevention  
• Explain the use of investigations for and management of individuals with non-
traditional CV risk factors  
• Discuss the management of clinical complications of patients with non-traditional CV 
risk factors 
• Outline proper laboratory testing or referral/collaboration with other specialists, in 




• Obtain a relevant history  
• Explore patient expectations, values and priorities 
• Evaluate non-traditional CV risk factors 
• Assess pharmacology of approved drugs, interactions, side effects in relation to 
cardiovascular and extracardiac complications  
• Interpret biochemical and imaging assessments and appropriately refer for complete 
and thorough assessment  
• Implement guidelines and protocols for diagnosis and management plans for non-
traditional risk factors  
• Select the appropriate investigations for refining non-traditional CV risk stratification 
• Manage lifestyle changes, and pharmacological treatment 
• Communicate with families, employers, other specialists and general practitioners 
• Motivate individuals to adopt healthier lifestyles, according to their special needs and 
preferences or health problems 
 




• Adopt a non-judgmental attitude regarding the individual lifestyle 
• Adopt a shared decision approach by actively engaging the patient in management 
decisions based on individual values, preferences, and associated conditions and co-
morbidities 
• Adopt a culture of interdisciplinary teamwork 
• Advocate for an integrated approach to chronic disease management, to include those 
with both traditional and non-traditional CV risk factors 
• Advocate for patient education on primary prevention as an essential component of 
cardiac care 
• Recognise  the importance of primary and secondary prevention in individuals and 
patients with non-traditional CV risk factors 





• Direct observation, workplace-based assessments ( e.g. DOPS, mini-CEX, fieldnotes) 
• Case-based discussions, entrustment-based discussions 
• Multiple consultant reports  
• Multi-source feedback  
 
Level of Independence 
 
• Level 4 (perform the activity under distant supervision. In this context this means to 
collaborate with experts of the clinical conditions associated with elevated CV risk) 
 
Related ESC Guidelines and EAPC Position Papers 
 
• Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of 
cardiovascular diseases during pregnancy. Eur Heart J 2018; 39: 3165-3241. 
 
• Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in 
clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on 
Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and 
by invited experts)Developed with the special contribution of the European Association for 
Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315-2381. Update 2021. 
 
• Zamorano JL, Lancellotti P, Rodriguez Munoz D, et al. 2016 ESC Position Paper on cancer treatments and 
cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The 
Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). 




Chapter 3: Secondary prevention and rehabilitation 395 
3.1 Manage a prevention and rehabilitation programme for a cardiovascular 396 
patient 397 





Scope and timeframe: 
All standard patients (outlined below) with an indication for a comprehensive CV prevention 
and rehabilitation programme 
From referral to follow-up after a structured programme 
 
Setting:  




Management of patients with acute coronary syndromes (ACS), chronic coronary syndromes 
(CCS), after coronary artery bypass graft (CABG), valve, and large vessel surgery, valve 
interventions, chronic heart failure, myocardial disease, congenital heart disease  
Complete evaluation and risk stratification using appropriate tests 
Lifestyle modification, through smoking cessation, nutritional, physical activity and psycho-
social counselling,  
Exercise prescription, exercise training structuring and supervision  
Cardiorespiratory performance and interpretation 
Guideline-directed medical therapy implementation 
Behavioural change and self-management 
Organisation and optimisation of a patient and family education programme 
Organisation of long-term follow-up 
 
Excluding: 
Patients with relevant comorbidities, cardiac implantable electrical devices (CIED), left 
ventricular assist devices (LVAD), heart transplantation (HTX) (see Chapter 3.2) 
Performing specialist investigations or interventional or surgical procedures, acute or unstable 














• Outline indications for comprehensive CV prevention and rehabilitation 
• Understand specific aspects of groups currently underrepresented in clinical studies 
(women, older people, ethnic minorities, migrants)  
• Describe current evidence and expected benefits of comprehensive CV prevention 
and rehabilitation  
• Consider appropriate referral and contraindication to comprehensive CV prevention 
and rehabilitation  
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• Outline the main core components of comprehensive CV prevention and 
rehabilitation programmes 
• Discuss the global patient evaluation strategy 
• Explain the different modalities of exercise 
• Outline the principles of the FITT-VP (frequency, intensity, time, type, volume, 
progression) model for exercise prescription and of using scales of perceived exertion 
(e.g. Borg) 
• Discuss indications and interpretation of exercise capacity tests (ECG exercise testing, 
CPET, 6MWT, strength tests)  
• Outline indication and mechanisms of guideline-directed medical therapies 
• Identify the interaction of pharmacological therapies with exercise  
• Identify the principles of counselling for secondary prevention 
• Describe psychological profiles and their impact on cardiovascular health 
• Describe the patient education management (empowerment, self-management, self-
efficacy, adherence promotion) 
• Discuss the new technologies and their use for remote monitoring, programme 
delivery, and education 
• Outline the composition and relationships of the interdisciplinary CV prevention and 
rehabilitation staff 




• Perform evaluation including CV risk factors, clinical condition, non-invasive 
assessment of CV functioning/disease, disabilities, nutrition, psycho-social impact 
• Explore patient expectations, values and priorities 
• Perform and analyse exercise capacity tests (ECG exercise test, CPET, six minutes 
walking tests (6MWT), strength tests) for tailored exercise prescriptions 
• Prescribe endurance continuous/interval training, resistance/strength training, 
balance training, and respiratory training 
• Coordinate psychosocial, nutrition, and smoking cessation counselling and integrate 
results in clinical shared decision making 
• Optimize and up-titrate guideline-directed medical therapies, under consideration of 
effects on exercise tolerance  
•  
• Develop exercise training according to settings (residential, ambulatory, community-
based, tele-monitoring), patient conditions (age, sex, psychology, comorbidities), and 
preferences 
• Assess nutritional habits and integrate into nutritional strategy 
• Conceptualise, organise and drive an educational programme  
• Organise a tele monitoring /tele-rehabilitation programme  
• Manage comorbidities 
• Recognize and treat emergency cases 
• Manage patients with residual ischemia (e.g. incomplete optimal revascularization, 
diffuse atherosclerotic disease) 
• Detect post-interventional or post-surgical complications (e.g. early stent thrombosis 
or restenosis, pericardial tamponade) 
• Apply effective communication and behavioural change techniques (e.g. motivational 
interviewing for smoking cessation and patient education) 
• Organise the follow up, links with general practitioners and/or cardiologists, and 
other health professionals 





• Adopt a non-judgmental attitude regarding individual lifestyle choices 
• Be aware of the influence of CV risk factors and diseases in patient prognosis 
(differentiate mortality and morbidity) and quality of life 
• Be aware of the importance of CV prevention and rehabilitation in the pathway and 
care delivery of the CV patient 
• Work in interdisciplinary teams with health professionals involved in secondary 
prevention 
• Deliver education, empathy and encouragement to the patient to reduce their CV risk 
factors with help of all the professional resources  
• Educate patients on how his/her entourage can support prevention  
• Support patients with genetic disorders (psychological counselling,  explain 
consequences for disease management and for relatives) 
• Motivate patient to sustain long term adherence with lifestyle, exercise training, and 
medical therapy 
• Actively involve the patient in shared decision making to promote optimal self- 
management and long term adherence to behaviour change   
• Advocate comprehensive cardiovascular prevention and rehabilitation programmes 





• Direct observation, workplace-based assessments ( e.g. DOPS, mini-CEX, fieldnotes) 
• Case-based discussions, entrustment-based discussions 
• Multiple consultant reports  
• Multi-source feedback  
 
Level of Independence 
 
• Level 5 (perform the activity without supervision, teach and supervise others) 
 
Related ESC Guidelines and EAPC Position Papers 
 
• Ambrosetti M, Abreu A, Corra U, et al. Secondary prevention through comprehensive cardiovascular 
rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary 
Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev 
Cardiol 2020 Mar 30. DOI: 10.1177/2047487320913379. 
 
• Abreu A, Frederix I, Dendale P, et al. Standardization and quality improvement of secondary prevention 
through cardiovascular rehabilitation programmes in Europe: The avenue towards EAPC accreditation 
programme: A position statement of the Secondary Prevention and Rehabilitation Section of the 
European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol 2020 Jun 1. DOI: 
10.1177/2047487320924912. 
 
• Scherrenberg M, Wilhelm M, Hansen D, et al. The future is now: a call for action for cardiac 
telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of 
the European Association of Preventive Cardiology. Eur J Prev Cardiol 2020 2020 Jul 2 DOI: 
10.1177/2047487320939671. 
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• Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in 
clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on 
Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and 
by invited experts)Developed with the special contribution of the European Association for 
Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315-2381. Update in 2021. 
 
• Mezzani A, Hamm LF, Jones AM, et al. Aerobic exercise intensity assessment and prescription in cardiac 
rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and 
Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the 
Canadian Association of Cardiac Rehabilitation. Eur J Prev Cardiol 2013; 20: 442-467. 
 
• Piepoli MF, Conraads V, Corra U, et al. Exercise training in heart failure: from theory to practice. A 
consensus document of the Heart Failure Association and the European Association for Cardiovascular 




3.2 Manage a prevention and rehabilitation programme for a cardiovascular 401 




Scope and timeframe:  
All complex patients (outlined below) with an indication for a comprehensive CV prevention 
and rehabilitation programme 
From referral to follow-up after a structured programme 
 
Setting:  




Management of patients with stroke, peripheral artery occlusive disease (PAOD, including 
amputation), diabetes, chronic kidney disease, chronic obstructive pulmonary disease, 
rheumatologic disease, orthopaedic disease, and frailty 
Management of CIED, LVAD, and HTX patients 
Patient global evaluation and risk stratification using appropriate tests 
Lifestyle modification, through nutritional, physical activity and psycho-social counselling; 
Adapted exercise prescription, adapted exercise training structuring and supervision 
Cardiorespiratory performance and interpretation (identifying those patients who cannot do 
it) 
Guideline-directed medical therapy implementation 
Behavioural change and self-management 
Organisation and optimisation of a patient education programme, including specific 
information related to the comorbidity 
Organisation of long-term follow-up 
 
Excluding: 
Performing specialist investigations or interventional or surgical procedures, acute or unstable 
conditions, acute settings 
 














• Discuss the management of individual comorbidities: stroke, PAOD, diabetes, chronic 
kidney disease, chronic obstructive pulmonary disease, rheumatologic disease, 
orthopaedic disease, and frailty 
• Discuss the management of CIED, LVAD and HTX patients 
• Describe the current evidence and expected benefits of comprehensive CV prevention 
and rehabilitation  
• Consider appropriate referral and contraindication to comprehensive CV prevention 
and rehabilitation programmes 
• Outline the main core components of comprehensive CV prevention and 
rehabilitation programmes 
• Discuss the global patient evaluation strategy 
• Identify the interaction between pharmacological and CIED therapies with exercise  
• Explain the different modalities of exercise and how to adapt to specific 
comorbidities, and frailty 
• Outline the principles of the FITT-VP (frequency, intensity, time, type, volume, 
progression) model for exercise prescription and of using scales of perceived exertion 
(e.g. Borg)  
• Discuss indications and interpretation of exercise capacity tests (ECG exercise testing, 
CPET, 6MWT, strength tests)  
• Know key frailty tests (i.e. timed up and go, walking speed test) and tests for cognitive 
deficits (mini-mental status test). 
• Identify the principles of counselling for secondary prevention, specifically including 
management linked to comorbidities 
• Describe psychological profiles and their impact on cardiovascular health 
• Describe the patient education management (empowerment, self-management, self-
efficacy, adherence promotion) 
• Discuss the new technologies and their use for remote monitoring, program delivery, 
and education 
• Outline the composition of and relationships between the interdisciplinary CV 
prevention and rehabilitation staff 
• Discuss how comorbidities influence CV prevention and rehabilitation delivery and 
need for adaptation 
• Discuss the influence of CV risk factors and diseases in patient prognosis (differentiate 
mortality and morbidity) and quality of life 
• Outline the importance of comprehensive CV prevention and rehabilitation in the 
pathway and care delivery of the CV patient without and with comorbidities 
Skills 
 2021 EAPC Core Curriculum Preventive Cardiology – first revision 14.01.2021 28 
 
 
• Manage specific aspects of individual comorbidities: stroke, PAOD, diabetes, chronic 
kidney disease, chronic obstructive pulmonary disease, rheumatologic disease, 
orthopaedic disease, and frailty 
• Manage specific aspects of CIED, LVAD and heart transplant patients 
• Perform evaluation including CV risk factors, clinical condition, non-invasive 
assessment of CV functioning/disease, disabilities, nutrition, psycho-social impact 
• Explore patient expectations, values and priorities 
• Perform and interpret exercise capacity tests (ECG exercise testing, CPET, 6MWT, 
strength tests) for tailored exercise prescriptions 
• Prescribe endurance continuous/interval training, resistance/strength training, and 
respiratory training 
• Develop exercise training according to settings (residential, ambulatory, community-
based, tele-monitoring), patient conditions (age, sex, comorbidities, psychologic 
status), and preferences 
• Conceptualise, organise and drive an educational programme with specificities to the 
different comorbidities 
• Organise a tele-monitoring /tele-rehabilitation programme  
• Optimise and up-titrate guideline-directed medical therapies, adapted to the exercise 
tolerance and comorbidities  
• Identify and analyse CIED functioning  at rest and during effort 
• Manage comorbidities under consideration of possible drug interactions and 
contraindications 
• Recognise and treat emergency cases related to comorbidities or devices 
• Manage patients with residual ischemia (e.g. incomplete optimal revascularization, 
diffuse atherosclerotic disease) 
• Detect post interventional or post-surgical complications (e.g. early stent thrombosis 
or restenosis, pericardial tamponade) 
• Apply effective communication and behavioural change techniques (e.g. motivational 
interviewing for smoking cessation and patient education) 
• Make end of life discussions possible for terminal patients 
• Organise the follow up, links with general practitioners and/or cardiologists, and 




• Work with interdisciplinary teams of health professionals involved in secondary 
prevention and rehabilitation 
• Educate and encourage patients to reduce their CV risk factors with help of all the 
professional resources  
• Educate patients on how his/her entourage can support prevention  
• Support patients with genetic disorders (psychological counselling,  explain 
consequences for disease management and for relatives) 
• Motivate patients to sustain long term adherence with lifestyle, exercise training, and 
medical therapy, despite their comorbidities 
• Actively involve patients in shared decision making to promote optimal self-
management and long term adherence to behaviour change   
• Advocate for comprehensive CV prevention and rehabilitation programmes to 
improve referral and uptake 
 





• Direct observation, workplace-based assessments ( e.g. DOPS, mini-CEX, fieldnotes) 
• Case-based discussions, entrustment-based discussions 
• Multiple consultant reports  
• Multi-source feedback  
 
Level of Independence 
 
• Level 5 (perform the activity without supervision, teach and supervise others) 
 
Related ESC Guidelines and EAPC Position Papers 
 
• Pedretti RF, Iliou MC, Israel CW et al. Comprehensive Multicomponent Cardiac Rehabilitation in Cardiac 
Implantable Electronic Devices Recipients. A Consensus Document from the European Association of 
Preventive Cardiology (EAPC; Section on Secondary Prevention and Rehabilitation) and European Heart 
Rhythm Association (EHRA). Eur J Prev Cardio 2020. DOI:10.1093/eurjpc/zwaa121.  
 
• Ambrosetti M, Abreu A, Corra U, et al. Secondary prevention through comprehensive cardiovascular 
rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary 
Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev 
Cardiol 2020 Mar 30. DOI: 10.1177/2047487320913379. 
 
• Abreu A, Frederix I, Dendale P, et al. Standardization and quality improvement of secondary prevention 
through cardiovascular rehabilitation programmes in Europe: The avenue towards EAPC accreditation 
programme: A position statement of the Secondary Prevention and Rehabilitation Section of the 
European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol 2020 Jun 1. DOI: 
10.1177/2047487320924912. 
 
• Scherrenberg M, Wilhelm M, Hansen D, et al. The future is now: a call for action for cardiac 
telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation section of 
the European Association of Preventive Cardiology. Eur J Prev Cardiol 2020 Jul 2. DOI: 
10.1177/2047487320939671. 
 
• Hansen D, Kraenkel N, Kemps H, et al. Management of patients with type 2 diabetes in cardiovascular 
rehabilitation. Eur J Prev Cardiol 2019; 26: 133-144. 
 
• Kemps H, Krankel N, Dorr M, et al. Exercise training for patients with type 2 diabetes and 
cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of 
Preventive Cardiology (EAPC). Eur J Prev Cardiol 2019; 26: 709-727. 
 
• Vigorito C, Abreu A, Ambrosetti M, Belardinelli R, Corra U, Cupples M, Davos CH, Hoefer S, Iliou MC, 
Schmid JP, Voeller H, Doherty P. Frailty and cardiac rehabilitation: A call to action from the EAPC Cardiac 
Rehabilitation Section. Eur J Prev Cardiol. 2017;24:577-590. 
 
• Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in 
clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on 
Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and 
by invited experts)Developed with the special contribution of the European Association for 
Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315-2381. Update in 2021. 
 
• Mezzani A, Hamm LF, Jones AM, et al. Aerobic exercise intensity assessment and prescription in cardiac 
rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and 
Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the 
Canadian Association of Cardiac Rehabilitation. Eur J Prev Cardiol 2013; 20: 442-467. 
 
• Piepoli MF, Conraads V, Corra U, et al. Exercise training in heart failure: from theory to practice. A 
consensus document of the Heart Failure Association and the European Association for Cardiovascular 
Prevention and Rehabilitation. Eur J Heart Fail 2011; 13: 347-357. 





3.3 Manage a cardiovascular prevention and rehabilitation programme for an 406 




Scope and timeframe:  
Cancer patients, in particular after cardiotoxic cancer therapy, from cancer diagnosis to 
follow-up surveillance  
 
Setting:  




Assessment of the clinical status, identification of risk factors for CVD and cancer, using basic 
and advanced tools for investigation; pharmacological and non-pharmacological treatment 
 
Excluding: 
Performing specialist investigations or interventional or surgical procedures, acute or unstable 








• Health advocate 
• Scholar 




• Identify clinical interactions between cancer and CVDs 
• Identify risk factors common to cancer and CVD (e.g. aging, smoking, alcohol abuse, 
unbalanced diet and physical inactivity) 
• Describe CV toxicity of specific chemo- and radiotherapies in cancer patients 
undergoing treatment as well as cancer survivors and its influence on exercise 
capacity and quality of life 
• Describe the prognosis of different cancers 
• Discuss the specific rehabilitation needs of cancer patients with or at risk of CVD 
(exercise, psychological, prevention, social, education) 
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• Describe the role of exercise in cardio-oncology rehabilitation to minimise the 
negative effects of cancer therapies (e.g. cardio-toxicity, fatigue, bone loss, 
lymphedema, autonomic dysfunction, depression, anxiety) 
• Discuss indications and interpretation of exercise capacity tests (ECG exercise testing, 
CPET, 6MWT, strength tests) 
• Describe the role of exercise and cardio-oncology rehabilitation to limit cancer 
progression and relapses  
• Discuss the strategies to limit disabilities, impaired quality of life and psychosocial 
distress induced by cancer and CVD 
Skills 
 
• Differentiate cardio-oncology rehabilitation in cancer patients from conventional 
oncology rehabilitation 
• Identify cancer patients with expected greater benefits from cardio-oncology 
rehabilitation 
• Adapt comprehensive cardio-oncology rehabilitation to the cancer situation (active 
cancer or cancer survivors) 
• Perform and interpret exercise capacity tests (ECG exercise testing, CPET, 6MWT, 
strength tests) for tailored exercise prescriptions 
• Interpret imaging investigations performed in oncology patients and derive 
prognostic information 
• Identify the appropriate cardio-oncology rehabilitation setting (residential, out-
patients, centre-based, community-based, home-based) according to patient’s 
preferences and possibilities 
• Review cancer history, cancer therapies and related side effects, drug interactions 
• Evaluate the risk of CVD in active cancer and cancer survivors 
• Establish goals for risk factors control modulated by the presence or history of cancer 
• Select the appropriate method of functional testing in cancer patients 
• Evaluate and treat cancer-related cachexia, sarcopenia and anaemia 
• Adapt type and intensity of training to cancer localization, cancer stages  and specific 
sequelae (e.g. appropriate intensity in case of cachexia or frailty, role of upper body 
strength training in breast cancer, role of inspiratory muscle training in thoracic 
cancer) 
• Interdisciplinary  work with the oncology team, and other healthcare professionals 
• Make end of life discussions possible for terminal patients 




• Aim to decrease the risk of CVD in cancer patients 
• Consider cardio-oncology rehabilitation as a standard of care for cancer patients and 
survivors at high risk for CVD 
• Deal optimistically with cancer  
• Collaborate with oncologists and other care providers in the field of oncology 
• Reassure and motivate cancer patients  
Assessment tools 
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• MCQs 
• Direct observation, workplace-based assessments ( e.g. DOPS, mini-CEX, fieldnotes) 
• Case-based discussions, entrustment-based discussions 
• Multiple consultant reports  
• Multi-source feedback  
  
Level of Independence 
 
• Level 5 (perform the activity without supervision, teach and supervise others) 
 
Related ESC Guidelines and EAPC Position Papers 
 
• Zamorano JL, Lancellotti P, Rodriguez Munoz D, et al. 2016 ESC Position Paper on cancer treatments and 
cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The 
Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). 
Eur Heart J 2016; 37: 2768-2801. 
 
        Related AHA Scientific Statement 
 
• Gilchrist SC, Barac A, Ades PA, et al. Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes 
in Cancer Patients and Survivors: A Scientific Statement from the American Heart Association. Circulation 
2019; 139: e997-e1012. 
 409 
 410 
Chapter 4: Sports cardiology and exercise 411 




Scope and timeframe:  
Competitive athletes, from evaluation to eligibility for competition 
 
Setting:  
Out-patient setting  
 
Including: 
Evaluation of personal and family history (including habitual physical activity level, sport type, 
fitness), physical examination, blood pressure measurement, 12-lead ECG, further testing 
(ambulatory ECG monitoring, echocardiography, advanced imaging, exercise testing, CPET), if 
appropriate  
Identification of potential high-risk athletes for sudden cardiac death and for other 
cardiovascular conditions that may worsen because of intensive athletic training 
 
Excluding: 




• Medical expert 










• Describe physiological adaptations to acute and chronic exercise 
• Describe physiological adaptations in different situations such as deep sea, high 
altitude, low or high temperatures 
• Assess the type of practiced sport (skill, power, mixed, endurance), the specific 
metabolic features and induced CV remodeling 
• Describe the physiological CV adaptation induced by regular exercise and the normal 
versus borderline ECG findings in athletes 
• Describe the incidence of sudden cardiac death in athletes and the most frequent and 
emergent CV conditions involved 
• Describe CV conditions that may worsen because of intensive athletic training and 
those that will benefit from primary prevention 
• Describe how to establish a diagnostic flowchart for sudden death prevention in the 
presence of abnormal findings (including ECG and physical examination findings) 
during pre-participation evaluation (PPE) in athletes 
• Describe indications for cardiac multi-modality imaging and genetic testing in PPE 
• Discuss the CV effects of the main doping substances  
Skills 
 
• Obtain a relevant history and perform an appropriate physical examination, including 
habitual physical activity level and sport type (skill, power, mixed, endurance) 
• Evaluate the CV risk profile based on appropriate risk calculators and the fitness level 
of an athlete over 35 years of age and the burden of risk factors for CVD 
• Understand the results of physical examination and 12-lead ECG showing 
physiological, borderline or pathological findings 
• Identify the potential high-risk athletes and further evaluate the risk of sudden 
cardiac death or acceleration of an inherited predisposition or exacerbation of cardiac 
damage due to intercurrent illness resulting from intense and prolonged exercise. 
• Evaluate potential doping issues and substance abuse 
• Choose the appropriate screening modality in the presence of abnormal findings (e.g. 
ECG exercise test, CPET, echocardiography, ambulatory ECG monitoring, CCTA, CMR, 
genetic testing) 
• Perform and interpret ECG exercise test, CPET, echocardiography, ambulatory ECG 
monitoring if indicated 
• Integrate results from advanced cardiovascular imaging and genetic testing in clinical 
decision making 
• Advise regarding exercise and exercise training in athletes with cardiac disease 
according to history, clinical finding, diagnostics and CPET 
Attitudes  
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• Adopt a non-judgmental attitude to an athlete regarding her/his lifestyle or referred 
symptoms, if any 
• Communicate with the athlete, family, and the team physician to optimize the 
management of potentially abnormal findings during PPE and how this may affect 
sports eligibility 
• Communicate concepts of exercise and exercise programme with the athlete 
• Motivate the athlete to systematically undergo PPE and explain the cost-effectiveness 




• Direct observation, workplace-based assessments ( e.g. DOPS, mini-CEX, fieldnotes) 
• Case-based discussions, entrustment-based discussions 
• Multiple consultant reports  
• Multi-source feedback  
 
Level of Independence 
 
• Level 5 (perform the activity without supervision, teach and supervise others) 
 
Related ESC Guidelines and EAPC Position Papers 
 
• Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with 
cardiovascular disease. Eur Heart J. 2020 Aug 29. DOI: 10.1093/eurheartj/ehaa605. 
 
• Budts W, Pieles GE, Roos-Hesselink JW, et al. Recommendations for participation in competitive sport in 
adolescent and adult athletes with Congenital Heart Disease (CHD): position statement of the Sports 
Cardiology & Exercise Section of the European Association of Preventive Cardiology (EAPC), the European 
Society of Cardiology (ESC) Working Group on Adult Congenital Heart Disease and the Sports Cardiology, 
Physical Activity and Prevention Working Group of the Association for European Paediatric and 
Congenital Cardiology (AEPC). Eur Heart J. 2020 Aug 26. DOI: 10.1093/eurheartj/ehaa501. 
 
• Heidbuchel H, Adami PE, Antz M, et al. Recommendations for participation in leisure-time physical 
activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: 
Part 1: Supraventricular arrhythmias. A position statement of the Section of Sports Cardiology and 
Exercise from the European Association of Preventive Cardiology (EAPC) and the European Heart Rhythm 
Association (EHRA), both associations of the European Society of Cardiology. Eur J Prev Cardiol. 2020 Jun 
29. DOI: 10.1177/2047487320925635. 
 
• Heidbuchel H, Arbelo E, D'Ascenzi F, et al. Recommendations for participation in leisure-time physical 
activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. 
Part 2: ventricular arrhythmias, channelopathies, and implantable defibrillators. Europace. 2020 Jun 29. 
DOI: 10.1093/europace/euaa106. 
 
• Pelliccia A, Solberg EE, Papadakis M, et al. Recommendations for participation in competitive and leisure 
time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the 
Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 
2019;40:19-33. 
 
• Borjesson M, Dellborg M, Niebauer J, et al. Recommendations for participation in leisure time or 
competitive sports in athletes-patients with coronary artery disease: a position statement from the 
Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 
2019;40:13-18. 
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• Niebauer J, Borjesson M, Carre F, et al. Recommendations for participation in competitive sports of 
athletes with arterial hypertension: a position statement from the sports cardiology section of the 
European Association of Preventive Cardiology (EAPC). Eur Heart J. 2018;39:3664-3671. 
 
• Mont L, Pelliccia A, Sharma S, et al. Pre-participation cardiovascular evaluation for athletic participants to 
prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by 
APHRS, HRS, and SOLAECE. Europace 2017; 19: 139-163. 
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4.2 Manage the work-up of an athlete with suspected or known 415 




Scope and timeframe: 
Leisure-time and competitive athletes, from the time the athlete with suspected or known 
CVD self-refers or is referred for a consultation until regular follow-up 
 
Setting: 
Most commonly out-patient setting, but also in-patient setting and emergency department 
 
Including:  
Assessment with history, physical examination, basic and advanced tools for investigation, 
differentiation of physiological adaptation to exercise from phenotypes of CVD, 
identification of risk factors for sudden cardiac death and high-risk conditions,  
recommendation of lifestyle and pharmacological treatment, exercise prescription and 
counselling on leisure-time and competitive sports 
 
Excluding: 
Performing specialist investigations or interventional or surgical procedures, interpreting 














• Describe phenotypes of physiological adaptation to exercise 
• Recognize the challenges of differentiating athlete’s heart from heart disease 
• Identify risk factors for sudden cardiac death and high-risk conditions 
• Outline non-pharmacological and pharmacological treatment of athletes with 
common CV conditions 
• Outline exercise recommendations in athletes with CVD 




• Obtain a focused history and perform appropriate physical examination 
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• Propose and perform appropriate non-invasive, first-line clinical investigations (12-
lead ECG, transthoracic echocardiogram, exercise testing/CPET, ECG monitor) to 
assess athletes with suspected or known cardiac disease 
• Propose further appropriate advanced investigations, including genetic testing 
• Integrate the results in an interdisciplinary setting 
• Illustrate how risk stratification of athletes with CVD informs their management 
• Prescribe tailored exercise recommendations based on CPET 
• Implement recommendations for exercise prescription and eligibility for participation 
in competitive sport in athletes with cardiac disease 
• Prescribe comprehensive CV prevention and rehabilitation for athletes with CVD, if 
indicated, and adopt programmes appropriately 
Attitudes  
 
• Integrate the results of investigations in an interdisciplinary setting 
• Communicate effectively results and exercise recommendations to the athletes, team 
doctors, coaches, families 
• Promote a shared-decision making model, particularly in conditions with limited 
evidence relating to the risk of exercise 
• Adopt a holistic approach to the impact of exercise restriction and disqualification from 






• Direct observation, workplace-based assessments ( e.g. DOPS, mini-CEX, fieldnotes) 
• Case-based discussions, entrustment-based discussions 
• Multiple consultant reports  
• Multi-source feedback  
 
Level of Independence 
 
• Level 4 (perform the activity under distant supervision . In this context this means to 
work in a network with dedicated sports cardiology referral centres in complicated 
cases.) 
 
Related ESC Guidelines and EAPC Position Papers 
 
• Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with 
cardiovascular disease. Eur Heart J. 2020 Aug 29. DOI: 10.1093/eurheartj/ehaa605. 
 
• Budts W, Pieles GE, Roos-Hesselink JW, et al. Recommendations for participation in competitive sport in 
adolescent and adult athletes with Congenital Heart Disease (CHD): position statement of the Sports 
Cardiology & Exercise Section of the European Association of Preventive Cardiology (EAPC), the 
European Society of Cardiology (ESC) Working Group on Adult Congenital Heart Disease and the Sports 
Cardiology, Physical Activity and Prevention Working Group of the Association for European Paediatric 
and Congenital Cardiology (AEPC). Eur Heart J. 2020 Aug 26. DOI: 10.1093/eurheartj/ehaa501. 
 
• Heidbuchel H, Adami PE, Antz M, et al. Recommendations for participation in leisure-time physical 
activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: 
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Part 1: Supraventricular arrhythmias. A position statement of the Section of Sports Cardiology and 
Exercise from the European Association of Preventive Cardiology (EAPC) and the European Heart 
Rhythm Association (EHRA), both associations of the European Society of Cardiology. Eur J Prev Cardiol. 
2020 Jun 29. DOI: 10.1177/2047487320925635. 
 
• Heidbuchel H, Arbelo E, D'Ascenzi F, et al. Recommendations for participation in leisure-time physical 
activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. 
Part 2: ventricular arrhythmias, channelopathies, and implantable defibrillators. Europace. 2020 Jun 29. 
DOI: 10.1093/europace/euaa106. 
 
• Pelliccia A, Solberg EE, Papadakis M, et al. Recommendations for participation in competitive and leisure 
time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the 
Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 
2019;40:19-33. 
 
• Borjesson M, Dellborg M, Niebauer J, et al. Recommendations for participation in leisure time or 
competitive sports in athletes-patients with coronary artery disease: a position statement from the 
Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 
2019;40:13-18. 
 
• Niebauer J, Borjesson M, Carre F, et al. Recommendations for participation in competitive sports of 
athletes with arterial hypertension: a position statement from the sports cardiology section of the 




Chapter 5: Cardiopulmonary exercise testing 420 
5.1 Use cardiopulmonary exercise testing for diagnosis, risk stratification and 421 




Scope and timeframe: 
Healthy individuals, athletes, individuals with CVD risk factors, and CVD patients. From 
indication for using CPET until communicating the results 
 
Setting: 
In-patient, out-patient, exercise physiology laboratory, on field 
 
Including: 
Performing a comprehensive CPET on a bicycle or treadmill, or other types of ergometers, or 
using mobile devices under real-life conditions (i.e. patient’s workplace, athlete on the field), 
with and without invasive measurements, interpreting and reporting the results 
 
Excluding:  
Complex cases with a predominant pulmonary problem which should be managed in 




• Medical expert 









• Understand CV exercise physiology and cardiorespiratory fitness 
• List the indications and contraindications for CPET in healthy individuals, patients with 
CVD, and athletes  
• Know the risk of CPET in infective patients and preventive measures for the personal 
• Know the potential complications of CPET 
• Define the key variables of CPET  
• Discuss the interpretation of the nine-panel plot 
• Discuss the indications for and value of additional blood gas analysis 
• Describe patterns of pulmonary, cardiac, and muscular conditions 
• List and detect pitfalls and artefacts of CPET  
• Describe the role of combining CPET with other (hemodynamic) evaluations (e.g. 
echocardiography, right heart catheterization) 




• Apply appropriate indications and avoid contraindication to CPET 
• Perform CPET calibration and quality control 
• Prepare the patient or athlete 
• Choose the appropriate exercise protocol and device 
• Interpret the nine-panel plot 
• Formulate a function-based diagnosis and prognostic stratification 
• Formulate exercise training recommendations based on ventilatory thresholds 




• Integrate CPET in the evaluation of healthy individuals, CV patients and athletes 
• Recognise the strengths and weaknesses of CPET in a clinical situation and in relation 
to other diagnostic modalities 
• Interact cooperatively with sports physicians, sports scientists, and paramedical staff 





• Direct observation, workplace-based assessments ( e.g. DOPS, mini-CEX, fieldnotes) 
• Case-based discussions, entrustment-based discussions 
• Multiple consultant reports  
  
Level of Independence 
 
• Level 5 (perform the activity without supervision, teach and supervise others) 
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Related ESC Guidelines and EAPC Position Papers 
 
• Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Joint Scientific Statement. Clinical 
recommendations for cardiopulmonary exercise testing data assessment in specific patient 
populations. Eur Heart J 2012; 33: 2917-2927. 
 
• Guazzi M, Arena R, Halle M, et al. 2016 focused update: clinical recommendations for cardiopulmonary 
exercise testing data assessment in specific patient populations. Eur Heart J 2018; 39: 1144-1161. 
 
• Mezzani A, Hamm LF, Jones AM, et al. Aerobic exercise intensity assessment and prescription in cardiac 
rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and 
Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the 




Figure Legends  426 
Figure 1 Preventive cardiology – domains, necessary competencies, and cooperation partners  427 
CPET, cardiopulmonary exercise testing; CV, cardiovascular 428 
 429 
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